Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G, Go RS; Mayo Clinic–University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. JAMA Oncol. 2022 Dec 1;8(12):1816-1820. doi: 10.1001/jamaoncol.2022.4432. JAMA Oncol. 2022. PMID: 36201194 Free PMC article.
Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.
Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29. Blood. 2019. PMID: 30696619 Free PMC article. Review. No abstract available.
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.
Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. Mayo Clin Proc. 2019. PMID: 31472931
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.
Goyal G, Abeykoon JP, Hu M, Young JR, Shah MV, Bennani NN, Call TG, Hook CC, Pardanani A, Inwards DJ, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Goyal G, et al. Am J Hematol. 2021 May 1;96(5):E146-E150. doi: 10.1002/ajh.26119. Epub 2021 Feb 19. Am J Hematol. 2021. PMID: 33539584 Free PMC article. No abstract available.
Mimics of Erdheim-Chester disease.
Abeykoon JP, Ravindran A, Rech KL, Young JR, Oliver Tobin W, Shah MV, Nora Bennani N, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. Br J Haematol. 2022 Feb;196(4):984-994. doi: 10.1111/bjh.17949. Epub 2021 Nov 20. Br J Haematol. 2022. PMID: 34799853
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.
Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. Am J Hematol. 2022 Mar 1;97(3):293-302. doi: 10.1002/ajh.26441. Epub 2022 Jan 3. Am J Hematol. 2022. PMID: 34978715 Free PMC article.
Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis.
Hu M, Goyal G, Abeykoon JP, Acosta-Medina AA, Ruan GJ, Young JR, Ravindran A, Bennani NN, Shah MV, Vassallo R, Ryu JH, Davidge-Pitts CJ, Koster MJ, Tobin WO, Sartori-Valinotti JC, Rech KL, Go RS. Hu M, et al. Blood Cancer J. 2022 Jun 3;12(6):89. doi: 10.1038/s41408-022-00685-7. Blood Cancer J. 2022. PMID: 35661109 Free PMC article. No abstract available.
Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Banks SA, et al. Ophthalmology. 2023 Jan;130(1):77-86. doi: 10.1016/j.ophtha.2022.07.031. Epub 2022 Aug 3. Ophthalmology. 2023. PMID: 35932838
Neurological Manifestations of Histiocytic Disorders.
Banks SA, Sartori Valinotti JC, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Bennani NN, Shah MV, Rech KL, Tobin WO; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology. Banks SA, et al. Curr Neurol Neurosci Rep. 2023 Jun;23(6):277-286. doi: 10.1007/s11910-023-01272-4. Epub 2023 May 20. Curr Neurol Neurosci Rep. 2023. PMID: 37209319 Review.
56 results